| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Bicara Therapeutics Inc. | Director | Common Stock | 29,991 | $397,183 | $13.24 | 12 Sep 2024 | Direct |
| Bicara Therapeutics Inc. | Director | Stock Option (Right to Buy) | 23,746 | 09 Jun 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| BCAX | Bicara Therapeutics Inc. | 09 Jun 2025 | 1 | $0 | 4 | Director | 10 Jun 2025, 16:29 |
| BCAX | Bicara Therapeutics Inc. | 12 Sep 2024 | 1 | $0 | 4 | Director | 16 Sep 2024, 16:42 |
| BCAX | Bicara Therapeutics Inc. | 12 Sep 2024 | 0 | $0 | 3 | Director | 12 Sep 2024, 21:03 |